NCL Method ITA-1
Analysis of Hemolytic Properties of Nanoparticles
Listed in Datasets | publication by group NCL Protocols
Version 2.0b - published on 24 Jul 2020 doi:10.17917/V9AP-D094 - cite this
Licensed under these terms
Description
Hemolysis refers to the damage of red blood cells leading to the release of intracellular erythrocyte content into blood plasma. Erythrocytes comprise approximately 45% of whole blood by volume. When hemolysis occurs in vivo, it can lead to anemia, jaundice and other pathological conditions which could become life threatening. Hemoglobin is a dominant intracellular protein of erythrocytes. It plays a key role in carrying oxygen to other cells and tissues. However, extracellular hemoglobin released upon hemolysis is toxic and may affect vascular, myocardial, renal and central nervous system tissues. Therefore, all medical devices and drugs which come into contact with blood are required to be tested for potential hemolytic properties.
Content List
- NCL_Method_ITA-1_May2020.pdf(PDF | 644 KB)
Cite this work
Researchers should cite this work as follows:
- Barry Neun, Anna Ilinskaya, Marina Dobrovolskaia (2020). NCL Method ITA-1. (Version 2.0b). NCI Hub. doi:10.17917/V9AP-D094
Tags
NCL Protocols
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.